421 related articles for article (PubMed ID: 27712399)
1. Priming Equine Bone Marrow-Derived Mesenchymal Stem Cells with Proinflammatory Cytokines: Implications in Immunomodulation-Immunogenicity Balance, Cell Viability, and Differentiation Potential.
Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Gosálvez J; Roy R; Zaragoza P; Martín-Burriel I; Rodellar C
Stem Cells Dev; 2017 Jan; 26(1):15-24. PubMed ID: 27712399
[TBL] [Abstract][Full Text] [Related]
2. Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Ranera B; Zaragoza P; Martín-Burriel I; Rodellar C
Vet Immunol Immunopathol; 2016 Mar; 171():57-65. PubMed ID: 26964718
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of equine bone marrow derived mesenchymal stem cells increases the expression of immunogenic genes.
Barrachina L; Remacha AR; Romero A; Zaragoza P; Vázquez FJ; Rodellar C
Vet Immunol Immunopathol; 2018 Jun; 200():1-6. PubMed ID: 29776607
[TBL] [Abstract][Full Text] [Related]
4. Inflammation affects the viability and plasticity of equine mesenchymal stem cells: possible implications in intra-articular treatments.
Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Ranera B; Zaragoza P; Martín-Burriel I; Rodellar C
J Vet Sci; 2017 Mar; 18(1):39-49. PubMed ID: 27297420
[TBL] [Abstract][Full Text] [Related]
5. Effect of allogeneic platelet lysate on equine bone marrow derived mesenchymal stem cell characteristics, including immunogenic and immunomodulatory gene expression profile.
Yaneselli K; Barrachina L; Remacha AR; Algorta A; Vitoria A; Cequier A; Romero A; Vázquez FJ; Maisonnave J; Rodellar C
Vet Immunol Immunopathol; 2019 Nov; 217():109944. PubMed ID: 31563725
[TBL] [Abstract][Full Text] [Related]
6. Isolation and prolonged expansion of oral mesenchymal stem cells under clinical-grade, GMP-compliant conditions differentially affects "stemness" properties.
Bakopoulou A; Apatzidou D; Aggelidou E; Gousopoulou E; Leyhausen G; Volk J; Kritis A; Koidis P; Geurtsen W
Stem Cell Res Ther; 2017 Nov; 8(1):247. PubMed ID: 29096714
[TBL] [Abstract][Full Text] [Related]
7. Thymoquinone influences the expression of genes involved in self-renewal and immunomodulatory potential of mouse bone marrow-derived mesenchymal stem cells in vitro.
Alimoradi E; Sisakhtnezhad S; Akrami H
Environ Toxicol Pharmacol; 2018 Jun; 60():216-224. PubMed ID: 29763882
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory Effect of Cytokines in the Differentiation of Mesenchymal Stem Cells: A Review.
Zahari W; Hashim SN; Yusof MF; Osman ZF; Kannan TP; Mokhtar KI; Ahmad A; Noordin KB
Curr Stem Cell Res Ther; 2017; 12(3):197-206. PubMed ID: 27306400
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment.
Cassano JM; Schnabel LV; Goodale MB; Fortier LA
Stem Cell Res Ther; 2018 Apr; 9(1):82. PubMed ID: 29615127
[TBL] [Abstract][Full Text] [Related]
11. Paracrine effect of inflammatory cytokine-activated bone marrow mesenchymal stem cells and its role in osteoblast function.
Li C; Li G; Liu M; Zhou T; Zhou H
J Biosci Bioeng; 2016 Feb; 121(2):213-9. PubMed ID: 26315505
[TBL] [Abstract][Full Text] [Related]
12. Improved osteogenesis and upregulated immunogenicity in human placenta-derived mesenchymal stem cells primed with osteogenic induction medium.
Fu X; Yang H; Zhang H; Wang G; Liu K; Gu Q; Tao Y; Chen G; Jiang X; Li G; Gu Y; Shi Q
Stem Cell Res Ther; 2016 Sep; 7(1):138. PubMed ID: 27649692
[TBL] [Abstract][Full Text] [Related]
13. The immunomodulation-immunogenicity balance of equine Mesenchymal Stem Cells (MSCs) is differentially affected by the immune cell response depending on inflammatory licensing and major histocompatibility complex (MHC) compatibility.
Cequier A; Vázquez FJ; Romero A; Vitoria A; Bernad E; García-Martínez M; Gascón I; Barrachina L; Rodellar C
Front Vet Sci; 2022; 9():957153. PubMed ID: 36337202
[TBL] [Abstract][Full Text] [Related]
14. The immunomodulatory function of equine MSCs is enhanced by priming through an inflammatory microenvironment or TLR3 ligand.
Cassano JM; Schnabel LV; Goodale MB; Fortier LA
Vet Immunol Immunopathol; 2018 Jan; 195():33-39. PubMed ID: 29249315
[TBL] [Abstract][Full Text] [Related]
15. Effects of Normal Synovial Fluid and Interferon Gamma on Chondrogenic Capability and Immunomodulatory Potential Respectively on Equine Mesenchymal Stem Cells.
Zayed M; Adair S; Dhar M
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203758
[TBL] [Abstract][Full Text] [Related]
16. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D
Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596
[TBL] [Abstract][Full Text] [Related]
17. In vitro analysis of equine, bone marrow-derived mesenchymal stem cells demonstrates differences within age- and gender-matched horses.
Carter-Arnold JL; Neilsen NL; Amelse LL; Odoi A; Dhar MS
Equine Vet J; 2014 Sep; 46(5):589-95. PubMed ID: 23855680
[TBL] [Abstract][Full Text] [Related]
18. Effects of pro-inflammatory cytokines on chondrogenesis of equine mesenchymal stromal cells derived from bone marrow or synovial fluid.
Zayed MN; Schumacher J; Misk N; Dhar MS
Vet J; 2016 Nov; 217():26-32. PubMed ID: 27810206
[TBL] [Abstract][Full Text] [Related]
19. Impact of bladder-derived acellular matrix, growth factors, and extracellular matrix constituents on the survival and multipotency of marrow-derived mesenchymal stem cells.
Antoon R; Yeger H; Loai Y; Islam S; Farhat WA
J Biomed Mater Res A; 2012 Jan; 100(1):72-83. PubMed ID: 21972045
[TBL] [Abstract][Full Text] [Related]
20. LIGHT (TNFSF14) Increases the Survival and Proliferation of Human Bone Marrow-Derived Mesenchymal Stem Cells.
Heo SK; Noh EK; Gwon GD; Kim JY; Jo JC; Choi Y; Koh S; Baek JH; Min YJ; Kim H
PLoS One; 2016; 11(11):e0166589. PubMed ID: 27835685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
